4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000950170-23-058894
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 850,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| King Michael CHIEF FINANCIAL OFFICER | 2023-10-30 | Grant or award · Employee Stock Option (right to buy) | +850,000 | 850,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…